TheraRadar

Pharma Intelligence, Simplified

← Back
Data updated: Mar 10, 2026

TG THERAPEUTICS, INC

OncologyImmunologyNeurology
Biotech

TG THERAPEUTICS, INC is a biotechnology company focused on Oncology, Immunology, Neurology.

2022
Since
1
Drugs
-
Trials
4
Approved (2yr)

Key Drugs

No active drugs

Recent Activity

BRIUMVI 2026-01-16
Labeling
BRIUMVI 2025-08-18
Labeling
BRIUMVI 2025-08-18
Labeling
BRIUMVI 2024-10-30
Labeling
SEC Filings Pro
Loading...

Therapeutic Focus

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Oncology 36%
0 drugs Phase 3: 2 Phase 2: 8 Phase 1: 7
Immunology 31%
0 drugs Phase 3: 5 Phase 2: 3 Phase 1: 1
Neurology 30%
0 drugs Phase 3: 5 Phase 2: 3
Dermatology 2%
0 drugs Phase 2: 1
Gastroenterology 1%
0 drugs Phase 1: 1

Pipeline Strength Pro

Loading...

Competitors Pro

Pfizer big-pharma
Oncology, Dermatology, Immunology, Gastroenterology
Eli Lilly big-pharma
Oncology, Immunology, Neurology, Dermatology
Bristol-Myers Squibb big-pharma
Oncology, Immunology, Gastroenterology, Neurology
Takeda big-pharma
Immunology, Oncology, Gastroenterology, Neurology
AbbVie big-pharma
Immunology, Oncology, Neurology